{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:09:17Z","timestamp":1781042957595,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.eprac.2023.03.271","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T22:07:20Z","timestamp":1679609240000},"page":"560-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of Type 2 Diabetes Mellitus in the Very Elderly: One Practice\u2019s Experience"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-8811","authenticated-orcid":false,"given":"Martin M.","family":"Grajower","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"LeRoith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib1","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of diabetes in older adults: an endocrine society","volume":"104","author":"Leroith","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2023.03.271_bib2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurjhf\/hfr116","article-title":"Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups","volume":"13","author":"Mogensen","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.eprac.2023.03.271_bib3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2337\/dc20-0876","article-title":"Glucose control, sulfonylureas, and insulin treatment in elderly people with type 2 diabetes and risk of severe hypoglycemia and death: an observational study","volume":"44","author":"Ling","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2023.03.271_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/dc20-0552","article-title":"Severe hypoglycemia, cardiac structure and function, and risk of cardiovascular events among older adults with diabetes","volume":"44","author":"Echouffo-Tcheugui","year":"2021","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jdiacomp.2016.03.018","article-title":"Meta-analysis: association between hypoglycaemia and serious adverse events in older patients","volume":"30","author":"Mattishent","year":"2016","journal-title":"J\u00a0Diabetes Complicat"},{"key":"10.1016\/j.eprac.2023.03.271_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/CIA.S23966","article-title":"Hypothyroidism in the elderly: diagnosis and management","volume":"7","author":"Bensenor","year":"2012","journal-title":"Clin Interv Aging"},{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib7","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2337\/dc21-1507","article-title":"Adherence to the American diabetes association\u2019s glycemic goals in the treatment of diabetes among older Americans, 2001\u20132018","volume":"45","author":"Le","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2023.03.271_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4158\/EP14290.OR","article-title":"Adding rapid-acting insulin or Glp-1 receptor agonist to basal insulin: outcomes in A community Setting1","volume":"21","author":"Dalal","year":"2015","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/clinem\/dgab065","article-title":"Raubenheimer P,et al. Efficacy and safety of dulaglutide in older patients: a post hoc analysis of the REWIND trial","volume":"106","author":"Riddle","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2023.03.271_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/dmrr.2588","article-title":"Efficacy and safety of lixisenatide in elderly (\u226565 years old) and very elderly (\u226575 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme","volume":"31","author":"Raccah","year":"2015","journal-title":"Diabetes Metabol Res Rev"},{"issue":"9","key":"10.1016\/j.eprac.2023.03.271_bib11","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/dom.13331","article-title":"Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: pooled analysis of the SUSTAIN 1-5 trials","volume":"20","author":"Warren","year":"2018","journal-title":"Diabetes Obes Metabol"},{"issue":"10","key":"10.1016\/j.eprac.2023.03.271_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2023.03.271_bib13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jamainternmed.2014.1824","article-title":"National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011","volume":"174","author":"Lipska","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","article-title":"Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management","volume":"7","author":"Amiel","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2023.03.271_bib15","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/dc20-2850","article-title":"Diabetic complications, and risk of dementia in patients with diabetes: results from a large U.K. Cohort study","volume":"44","author":"Zheng","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2023.03.271_bib16","series-title":"Fear of hypoglycemia-An underestimated problem","author":"Przezak","year":"2022"},{"issue":"8","key":"10.1016\/j.eprac.2023.03.271_bib17","doi-asserted-by":"crossref","first-page":"e3047","DOI":"10.1002\/dmrr.3047","article-title":"Glycemic variability in the development of cardiovascular complications in diabetes","volume":"34","author":"Nusca","year":"2018","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"1","key":"10.1016\/j.eprac.2023.03.271_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2020.7848","article-title":"Association of statin use with all-cause and cardiovascular mortality in US veterans 75 Years and older","volume":"324","author":"Orkaby","year":"2020","journal-title":"JAMA, J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00125-020-05370-7","article-title":"Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study","volume":"65","author":"Lega","year":"2021","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.eprac.2023.03.271_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ageing\/afv067","article-title":"Pharmacotherapy for type 2 diabetes in very elderly patients: practicing nihilism or pragmatism?","volume":"44","author":"Dhatariya","year":"2015","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/dci22-0004","article-title":"Individualized glycemic goals for older adults are a moving target","volume":"45","author":"Pilla","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/dc09-1278","article-title":"Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial","volume":"33","author":"Riddle","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2023.03.271_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1479164118825376","article-title":"Pioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes","volume":"16","author":"DeFronzo","year":"2019","journal-title":"Diabetes Vasc Dis Res"},{"issue":"5","key":"10.1016\/j.eprac.2023.03.271_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2023.03.271_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/er.2018-00163","article-title":"Thyroid dysfunction and diabetes Mellitus: two closely associated disorders","volume":"40","author":"Biondi","year":"2019","journal-title":"Endocrine Reviews"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23003348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23003348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:14:34Z","timestamp":1761516874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23003348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1530891X23003348"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.03.271","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Type 2 Diabetes Mellitus in the Very Elderly: One Practice\u2019s Experience","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.03.271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}